The researchers uncovered this phenomenon by exposing mouse embryonic stem cells to a compound employed in the treatment of certain cancers. The molecule modifies chromatin compaction² by activating some genes while preventing the transcription of others. To further validate their hypothesis, the team experimentally removed specific 3D genomic structures. Once they were lost, the cells could no longer retain their memory of the past exposure.